Overview

Inhibition of Aldosterone in Patients With Chronic Renal Disease

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to examine whether the inhibition of aldosterone will result in lower excretion of protein via urine. The hypothesis is that if loss of protein is lowered, progression of renal disease with be slower than otherwise expected.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Lene Boesby
Collaborator:
Rigshospitalet, Denmark
Treatments:
Eplerenone
Criteria
Inclusion Criteria:

- Proteinuria > 500 mg/24 hours

- Hypertension or anti-hypertensive treatment

Exclusion Criteria:

- Diabetic nephropathy

- GFR< 20 ml/min

- P-potassium between 3,5 mmol/l and 5,0 mmol/l